Dr. Troy Rohn has built a substantial academic reputation with over 28 years of experience in neuroscience research and teaching. He earned his Ph.D. from the University of Washington in 1994 and completed postdoctoral training at INSERM (Paris), Montana State University, and UC Irvine’s Institute for Memory Impairments and Neurological Disorders. He has authored more than 80 peer-reviewed publications, placing him among the top 0.5% of scholars globally in his field for his contributions to Alzheimer’s research and neurological disorders. He’s currently a professor at Boise State University and Co-founder/Director of Preclinical Studies at Cognigenics.

Among the 80 peer-reviewed publications that Dr. Rohn has authored, many address topics related to neurobiology, mental health, and treatment strategies, making him a credible voice in the scientific community. He has also written articles for a general audience, including two for The Conversation. Collectively, these two articles have been viewed 212,00 times. More recently, he has written an article for The Academic entitled “Embracing a new era in medicine through gene therapy.”

 In his new book ‘Brain Medicine,’ Dr. Rohn has a gift for explaining complex scientific topics in an interesting and understandable way. He discusses the new revolutionary gene therapies developed for anxiety & other neuropsychiatric disorders. These therapies have unprecedented precision, without the common undesirable side effects of traditional drug therapies. Results in animal studies & preclinical trials have been remarkable. Part of what makes Dr. Rohn's work so compelling is that it has a rare and unique authenticity as he hasn’t just studied anxiety but also lived with it! Mental health is an issue he approaches with compassion while striving to create meaningful change.